20/20 Biolabs Inc.
NASDAQ: AIDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Jonathan Cohen
- Employees
- 14
- Headquarters
- Gaithersburg, United States
- IPO year
- 2026
- Market cap
- $3.4M
- Website
- https://2020biolabs.com
Loading AIDX…
Loading profile data…Frequently asked questions about AIDX
What does 20/20 Biolabs Inc. (AIDX) do?
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. I...
Where does AIDX trade?
20/20 Biolabs Inc. (AIDX) trades on the NASDAQ.
What sector is AIDX in?
20/20 Biolabs Inc. (AIDX) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of 20/20 Biolabs Inc.?
Jonathan Cohen is the chief executive officer of 20/20 Biolabs Inc. (AIDX).
Where is 20/20 Biolabs Inc. headquartered?
20/20 Biolabs Inc. is headquartered in United States.
Does AIDX pay a dividend?
20/20 Biolabs Inc. (AIDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AIDX go public?
20/20 Biolabs Inc. (AIDX) completed its initial public offering in 2026.